LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New 3D App Provides More Accurate Cancer Diagnosis

By LabMedica International staff writers
Posted on 16 Oct 2017
Print article
Image: Three-dimensional images showing the complex vascular system in ovarian cancer (left) and bladder cancer (right). Thick vessels are colored red, thin vessels colored blue (Photo courtesy of Nobuyuki Tanaka / Karolinska Institutet).
Image: Three-dimensional images showing the complex vascular system in ovarian cancer (left) and bladder cancer (right). Thick vessels are colored red, thin vessels colored blue (Photo courtesy of Nobuyuki Tanaka / Karolinska Institutet).
With further development of light-sheet microscopy based 3D imaging, researchers were able to examine tumor biopsy tissue in more detail than current 2D methods, resulting in improved intratumoral heterogeneity phenotyping and diagnosis of solid tumors.

Vast numbers of tumor tissue samples are examined by pathologists around the world, whose pronouncements inform the treatment patients are given. Mistakes can result in more suffering and sometimes death. Current pathological examination methods for assessing tumors use two-dimensional (2D) light microscopy, which can cause a major information gap in studying 3D objects.

“To be sure, the tumors can be divided into sections for individual study, but 3D structures such as the blood and lymph systems are very hard to study in this way,” said study lead investigator Per Uhlén, professor at Karolinska Institutet (Solna, Stockholm, Sweden). To better study human tumor tissue, the researchers applied an imaging technique, currently being used in basic research, that involves making the tissue transparent (clearing) and then reproducing it in 3D in a light-sheet microscope. For example, upon labeling with specific antibodies, certain proteins can be analyzed in more detail.

“Light-sheet microscopy has been used in basic research for a while, but it is only in recent years that it’s been refined so much that it can be used practically in hospitals,” said Prof. Uhlén, “It was an unforgettable experience to look inside a tumor from a patient for the first time.”

Working with clinicians from Karolinska University Hospital, the researchers were able to study stored samples from patients with bladder cancer and then by 3D reproduction of, amongst other structures, the blood system feeding the tumors, they could find more information about how aggressive the tumors are. The new technique also enabled more accurate diagnosis of muscle-invasive tumors, which can be missed with 2D methods.

“We’ve also studied other cancer types and judge that the method has considerable potential in the clinical diagnosis of all forms of solid tumors, especially cases that are difficult to diagnose,” said Prof. Uhlén.

The light-sheet microscope used for the study is one of only a few in Sweden and is housed at the core facility CLICK – the Center for Live Imaging of Cells at Karolinska Institutet.

The study, by Tanaka N et al, was published October 2, 2017, in the journal Nature Biomedical Engineering.

Related Links:
Karolinska Institutet

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more